Pharm Exec speaks to Florent Edouard, SVP and global head of commercial excellence at the Gr nenthal group, and Jan van den Burg, vice president for commercial strategy at Veeva in Europe, about how the COVID-19 pandemic is changing the way the industry reaches and engages with its customers.Original Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.